The U.S. Department of Health and Human Services (HHS) has launched a new initiative called the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. This project aims to significantly reduce the time and cost associated with developing new drugs by innovating clinical trial design. The program will fund teams to explore methods such as phaseless trials, real-time data analysis, and automation to streamline the drug development process and enhance U.S. competitiveness in the biotech sector. AI
IMPACT Could significantly reduce drug development timelines and costs, potentially accelerating the availability of new treatments.
RANK_REASON Launch of a new government program aimed at improving a major industry process. [lever_c_demoted from significant: ic=1 ai=0.4]
- ARPA-H
- Alicia Jackson
- clinical trial
- Daria Fedyukina
- Kyle Diamantas
- Mehmet Oz
- Robert F. Kennedy, Jr.
- SURPASS
- United States Department of Health and Human Services
- FDA
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →